Patent File Information
Application Information
Applicants
Person No Name Address
7822804 REGENERON PHARMACEUTICALS INC.
Inventors
Person No Name Address
7822797 Eric SMITH C/O REGENERON PHARMACEUTICALS, INC. 777 OLD SAW MILL RIVER ROAD TARRYTOWN, NEW YORK 10591 A.B.D.
7822798 Kara OLSON C/O REGENERON PHARMACEUTICALS, INC. 777 OLD SAW MILL RIVER ROAD TARRYTOWN, NEW YORK 10591 A.B.D.
7822799 Frank DELFINO C/O REGENERON PHARMACEUTICALS, INC. 777 OLD SAW MILL RIVER ROAD TARRYTOWN, NEW YORK 10591 A.B.D.
7822803 Qian ZHANG C/O REGENERON PHARMACEUTICALS, INC. 777 OLD SAW MILL RIVER ROAD TARRYTOWN, NEW YORK 10591 A.B.D.
7822801 Jessica KIRSHNER C/O REGENERON PHARMACEUTICALS, INC. 777 OLD SAW MILL RIVER ROAD TARRYTOWN, NEW YORK 10591 A.B.D.
7822802 Olga SINESHCHEKOVA C/O REGENERON PHARMACEUTICALS, INC. 777 OLD SAW MILL RIVER ROAD TARRYTOWN, NEW YORK 10591 A.B.D.
7822800 David DILILLO C/O REGENERON PHARMACEUTICALS, INC. 777 OLD SAW MILL RIVER ROAD TARRYTOWN, NEW YORK 10591 A.B.D.
Invention Information
Name Of Invention BİSPESİFİK ANTİ-BCMA X ANTİ-CD3 ANTİKORLARI VE BUNLARIN KULLANIMLARI
Summary Of Invention Mevcut buluş, B-hücresi olgunlaşma antijenini (BCMA) ve CD3'ü bağlayan bispesifik antijen bağlayıcı moleküller (örn. bispesifik antikorlar) ve bunların kullanım yöntemleri ile ilgilidir.
Attorney Information
Name ZEHRA KÖLÜK
DESTEK PATENT A.Ş.
Address Maslak mah. Saat sk. Spıne tower no:5 Sarıyer/ İSTANBUL
Priority Information
Date of Priority Priority Number Country of Priority
19-07-2018 US 201862700596P US
26-10-2018 US 201862750968P US
17-01-2019 US 201962793645P US
Classes of The Invention
IPC
A61K39/00
A61P35/02
C07K16/28
Patent Application Procedures
Date Date of Notification Operation Document
14-02-2025 Şekli Kontrol Yapıldı. Başvuru / İstem / Fasikül Onaylandı.
11-02-2025 EPO'dan Gelen Patent Fasikül
Publications
Publication Date Description
21-02-2025 Avrupa Patent Fasiküllerinin İlanı
Payment Dates
Row Year Payment Date Amount Paid (₺)